Operating costs and other operating income - Summary of R&D expenditure by program (Details) - EUR (€) € in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Operating costs and other operating income | |||
| Total R&D expenses | € (459,421) | € (335,459) | € (241,294) |
| SIKi program | |||
| Operating costs and other operating income | |||
| Total R&D expenses | (12,772) | (18,400) | (18,900) |
| TYK2 program on GLPG3667 | |||
| Operating costs and other operating income | |||
| Total R&D expenses | (36,744) | (34,965) | (31,289) |
| CAR-T programs in oncology | |||
| Operating costs and other operating income | |||
| Total R&D expenses | (295,610) | (170,998) | (82,218) |
| Other programs | |||
| Operating costs and other operating income | |||
| Total R&D expenses | € (114,295) | € (111,096) | € (108,887) |